Beijing DIA-UP Biotechnology Co, Ltd was established in 2012. It has a professional technology research and development team with over 10 years of experience and has won multiple invention patents. The company has built an in vitro diagnostic raw material research and development platform (covering 10 major product systems, including primer and probe synthesis, nucleic acid molecular detection raw materials, immune reagent raw materials, biochemical reagent raw materials, hemagglutination reagent raw materials, fluorescence immunochromatography POCT large board, biochemical reagent large package, hemagglutination reagent large package, calibration quality control products, etc.), automated high-throughput DNA reading and writing platform, RNA Intelligent design and synthesis platform, protein antibody preparation platform Five core technology platforms, including the supply platform for scientific research reagents and consumables.

DIA-UP Biotechnology adopts a 100000/10000 level purification workshop for product production and packaging, strictly adhering to the ISO13485:2016 quality management system standards, adhering to the development concept of 'craftsmanship quality, customer achievement', and committed to providing high-quality products and services to customers in the field of in vitro diagnosis and scientific research.